首页> 美国卫生研究院文献>Frontiers in Neurology >Pre-hospital Assessment of Large Vessel Occlusion Strokes: Implications for Modeling and Planning Stroke Systems of Care
【2h】

Pre-hospital Assessment of Large Vessel Occlusion Strokes: Implications for Modeling and Planning Stroke Systems of Care

机译:大型血管闭塞性中风的院前评估:对护理中风系统建模和计划的启示

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The social and financial burden of stroke is remarkable. Stroke is a leading cause of death and long-term disability worldwide. For several years, intravenous recombinant tissue plasminogen activator (IV rt-PA) remained as the only proven therapy for acute ischemic stroke. However, its benefit is hampered by a narrow therapeutic window and limited efficacy for large vessel occlusion (LVO) strokes. Recent trials of endovascular therapy (EVT) for LVO strokes have demonstrated improved patient outcomes when compared to treatment with medical treatment alone (with or without IV rt-PA). Thus, EVT has become a critical component of stroke care. As in IV rt-PA, time to treatment is a crucial factor with high impact on outcomes. Unlike IV rt-PA, EVT is only available at a limited number of centers. Considering the time sensitive benefit of reperfusion therapies of acute ischemic stroke, costs and logistics associated, it is recommended that regional systems of acute stroke care should be developed. These should include rapid identification of suspected stroke, centers that provide initial emergency care, including administration of IV rt-PA, and centers capable of performing endovascular stroke treatment with comprehensive periprocedural care to which rapid transport can be arranged when appropriate. In the pre-hospital setting, the development of scales easier and quicker to perform than the NIHSS yet with a maintained accuracy for detecting LVO strokes is of paramount importance. Several scales have been developed. On the other hand, the decision whether to transport to a primary stroke center (PSC) or to a comprehensive stroke center (CSC) is complex and far beyond the simple diagnosis of a LVO. Ongoing studies will provide important answers to the best transfer strategy for acute stroke patients. At the same time, the development of new technologies to aid in real time the decision-making process will simplify the logistics of regional systems for acute stroke care and, likely improve patients' outcomes through tailored selection of the most appropriate recanalization strategy and destination center.
机译:中风的社会和经济负担是巨大的。中风是世界范围内导致死亡和长期残疾的主要原因。几年来,静脉内重组组织纤溶酶原激活剂(IV rt-PA)仍然是急性缺血性卒中的唯一有效疗法。但是,它的好处因狭窄的治疗范围和对大血管闭塞(LVO)中风的疗效有限而受到阻碍。 LVO卒中的血管内治疗(EVT)的最新试验表明,与仅接受药物治疗(有或没有IV rt-PA)相比,患者的预后有所改善。因此,EVT已成为中风护理的重要组成部分。与IV rt-PA一样,治疗时间是对结局具有重大影响的关键因素。与IV rt-PA不同,EVT仅在少数几个中心可用。考虑到急性缺血性中风的再灌注治疗对时间敏感的好处,成本和相关的物流,建议应建立区域性急性中风护理系统。这些措施应包括:快速识别可疑中风;提供包括IV rt-PA在内的初步急诊服务的中心;以及能够进行血管内中风治疗并提供全面围手术期护理的中心,可以在适当时安排快速运输。在院前环境中,秤的开发比NIHSS更容易,更快捷,同时保持LVO卒中检测的准确性也至关重要。已经开发了几种量表。另一方面,是转移到主要卒中中心(PSC)还是转移到综合卒中中心(CSC)的决定是复杂的,远远超出了LVO的简单诊断范围。正在进行的研究将为急性中风患者的最佳转移策略提供重要的答案。同时,开发新技术以实时辅助决策过程,将简化急性中风护理区域系统的物流,并可能通过量身定制最合适的再通气策略和目的地中心来改善患者的预后。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号